Saturday, January 14, 2017 10:54:58 AM
I thought the company looked good when I just knew about their MNP Platform and Estrasorb but the nano-cannabinoid research and the info posted on the reformulated API's takes this to a whole other level.
I could not find many companies out there conducting transdermal or nano-cannabinoid research, I'd say their closest competitor would probably be Zynerba Pharmaceuticals (NASDAQ: ZYNE), In many ways I feel like NewGen actually looks better than ZYNE though.
ZYNE did a NASDAQ IPO so they are on a better exchange and have more cash, however, at least $100M has been invested into developing NewGens MNP Platform and it has FAR more flexibility vs simply the two products that ZYNE is developing.
I think this is going to be a company to watch in 2017, if they can manage to keep dilution at a minimum and not enter into any toxic convertible financing deals this could be pretty epic IMO.
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM